Neonatal hemoglobinopathy screening: Molecular genetic technologies

Molecular Genetics and Metabolism

Volumn 80, Issue 1-2, 2003, Pages 129-137

  Bhardwaj, Urvashi ^a,b   Zhang, Yao Hua ^a,b   McCabe, Edward R B ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HETERODUPLEX; OLIGONUCLEOTIDE; PENICILLIN G;

ALLELE; AUTOMATION; BETA THALASSEMIA; CHILDHOOD DISEASE; COST BENEFIT ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DIAGNOSTIC ACCURACY; DNA EXTRACTION; DNA MICROARRAY; DOT HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENE PROBE; GENE SEQUENCE; GENE TECHNOLOGY; GENETIC ANALYSIS; GLOBIN GENE; HEALTH CARE COST; HEMOGLOBINOPATHY; HETERODUPLEX ANALYSIS; HUMAN; LABORATORY TEST; MOLECULAR GENETICS; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION MAPPING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SHORT SURVEY; SICKLE CELL ANEMIA; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0142058062     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.08.014     Document Type: Short Survey

References (99)

1. Guthrie R., Susi A. A simple method for detecting phenyketonuria in large populations of newborn infants. Pediatrics. 32:1963;338-343.
2. President's commission for the study of ethical problems in medicine and biomedical research. Screening and counseling for genetic conditions: a report on the ethical, social and legal implications of genetic screening, counseling and education programs. Washington, DC: US Government Printing Office, 1983.
3. Guthrie R. Organization of a regional newborn screening laboratory. Bickel H., Guthrie R., Hemmersen G. National Screening for Inborn Errors of Metabolism. 1980;259-270 Springer, Berlin.
4. McCabe L.L., Therrell B.L. Jr., McCabe E.R. Newborn screening: rationale for a comprehensive, fully integrated public health system. Mol. Genet. Metab. 77:2002;267-273.
5. Khoury M.J., McCabe L.L., McCabe E.R. Population screening in the age of genomic medicine. N. Engl. J. Med. 348:2003;50-58.
6. GAO, United States General Accounting Office. Newborn screening, characteristics of state programs, March 2003.
7. Newborn Screening Task Force. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs. Pediatrics 106S (2000) 386-427.
8. Newborn Screening Committee, The Council of Regional Networks for Genetic Services (CORN), National Newborn Screening Report-1995, CORN, Atlanta, Sept 1999.
9. Gaston M.H., Verger J.I., Woods G.et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N. Eng. J. Med. 314:1986;1593-1599.
10. Wethers D.L. Panel, Newborn screening for sickle cell disease and other hemoglobinopathies. National Institutes of Health Consensus Development Conference Statement. 6:1987;1-22.
11. Zeuner D., Ades A.D., Karnon J., Brown J., Dezaterux C., Anionwu E.N. Antenatal and neonatal hemblobinopathies screening in the UK: review and economic analysis. Health Technol. Assess. 3:1999.
12. Lorey F., Cunningham G., Vichinsky E.P., Lubin B.H., Witkowska H.E., Matsunaga A., Azimi M., Sherwin J., Eastman J., Farina F., Waye J.S., Chui D.H.K. Universal Newborn Screening for Hb H disease in California. Genet. Test. 5:2001;93-100.
13. International committee for standardization in hematology. Recommendations for neonatal screening for hemoglobinopathies, Clin. Lab. Hematol. 10 (1988) 335-345.
14. Chapman C.S. Neonatal screening for hemoglobinopathies. Clin. Lab. Hematol. 21:1999;229-234.
15. Lafferty J. College of American Pathologists Hemoglobinopathy Survey HG-B. 1999;College of American Pathologists, Chicago, IL.
16. Clarke G.M., Higgins T.N. Laboratory investigation of hemoglobinopathies and thalassemia: review and update. Clin. Chem. 46:2000;1284-1290.
17. Galacteros F., Kleman K., Caburi-Martin J., Rosa J., Lubin B. Cord blood screening for hemoglobin abnormalities by thin layer isoelectric focusing. Blood. 56:1980;1068-1078.
18. Campbell M., Henthorn J.S., Davies S.C. Evaluation of cation-exchange HPLC compared with isoelectric focusing for neonatal hemoglobinopathy screening. Clin. Chem. 45:1999;969-975.
19. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management and counseling in newborns and infants (Clinical Practice Guideline 6) Rockville MD: US Department of Health and Human Sciences, 1993.
20. Kinney T., Sawtschenko M., Whorton M., Shearin J., Stine C., Hofman L., Safko R., Vitaglione T., Kaufman R.E. Technique, comparison and report of North Carolina experience. Pediatrics. 83(Suppl.):1989;843-848.
21. Henderson S.J., Fishlock K., Horn M.E., Oni L., Bellingham A.J. Neonatal screening for the hemoglobin variants using filter-paper dried blood specimens. Clin. Lab. Hematol. 13:1991;327-334.
22. Kleman K.M., Vichinski E., Lubin B.H. Experience with newborn screening using isoelectric focusing. Pediatrics. 83(Suppl.):1989;852-854.
23. Van den Jijs F.P.L., Van den Verg G.A., Schermer J.G., Muskiet F.D., Landman H., Muskiet F.A.J. Screening of cord blood for hemoglobinopathies and thalassemia by HPLC. Clin. Chem. 38:1992;1864-1869.
24. M. Wilborn, B.L. Therrell, E.R.B. McCabe, Newborn screening for sickle cell disease in transfused infants (Abstract) National Newborn Screening Meeting. June 7-11, Seattle, Washington, 1994.
25. Reed W., Lane P.A., Lorey F., Bojanowski J., Glass M., Louie R.R., Lubin B.H., Vichinsky E.P. Sickle cell disease not identified by newborn screening because of prior transfusion. J. Pediatr. 136:2000;145-146.
26. Frost B.A., Bellingham A.J. Neonatal hemoglobinopathy screening. Acta Hematol. 78:1987;142-143.
27. British Committee for Standards in Haematology, The laboratory diagnosis of hemoglobinopathies, Br. J. Hematol. 101 (1998) 783-792.
28. McCabe E.R.B., Huang S.-Z., Seltzer W.K., Law M.L. DNA microextraction from dried blood spots on the filter paper blotters: potential applications to newborn screening. Hum. Genet. 75:1987;213-216.
29. Zhang Y.-H., McCabe L., Wilborn M., Therrell B.L., McCabe E.R.B. Application of molecular genetics in public health: improved follow-up in a neonatal hemoglobinopathy screening program. Biochem. Med. Metab. Biol. 52:1994;27-35.
30. Jinks D.C., Minter M., Tarver D.A., Vanderford M., Hejtmancik J.F., McCabe E.R. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum. Genet. 81:1989;363-366.
31. McCabe E.R.B. Utility of PCR for DNA analysis from dried blood spots on filter paper blotters. PCR Methods Appl. 1:1991;99-106.
32. Descartes M., Huang Y., Zhang Y.-H., McCabe L., Gibbs R., Therrell B.L., McCabe E.R.B. Genotypic confirmation from original dried blood specimens in a neonatal hemoglobinopathy screening program. Ped. Res. 31:1991;217-221.
33. Angastiniotis M., Modell B. Global epidemiology of hemoglobin disorders. Ann. NY. Acad. Sci. 850:1998;251-259.
34. Weatherall D.J., Clegg J.B. The Thalassemia Syndromes. fourth ed. 2001;237-286 Blackwell Science, Oxford.
35. Huisman T.H.J., Carver M.F.H., Baysal E. A Syllabus of Thalassemia Mutations 1-309. 1997;The Sickle Cell Anemia Foundation, Augusta, Georgia.
36. Pirastu M., Ristaldi M.S., Cao A. Prenatal diagnosis of β-thalassemia based on restriction endonuclease analysis of amplified fetal DNA. J. Med. Genet. 26:1989;363-367.
37. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350-1354.
38. Haliassos A., Chomel J.C., Tesson L., Baudis M., Kruh J., Kaplan J.C., Kitzis A. Modification of the enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 17:1989;3606.
39. Sorscher E.J., Huang Z. Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosa. Lancet. 337:1991;1115-1118.
40. Chang J.-G., Chen P.-H., Chiou S.-S., Lee L.-S., Perng L.-I., Liu I.T.-C. Rapid diagnosis of β-thalassemia mutations in Chinese by naturally and amplified created restriction sites. Blood. 8:1992;2092-2096.
41. Lindeman R., Hu S.P., Valpato F., Trent R.J. Polymerase chain reaction mutagenesis enabling rapid non-radioactive detection of common β-thalassemia in Mediterraneans. Br. J. Hematol. 78:1991;100-104.
42. Xu X.-M., Ma W.-F., Song L.-L., Xu Q., Zhang J.-Z. Direct genotyping and prenatal diagnosis β-thalassemia in Chinese by polymerase chain reaction mediated restriction fragment length polymorphism method. Clin. Biochem. 26:1993;497-503.
43. Ristaldi M.S., Pirastu M., Rosatelli C., Monni G., Erlich H., Saiki R., Cao A. Prenatal diagnosis of beta-thalassemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes. Prenat. Diagn. 9:1989;629-638.
44. Sylvester-Jackson D., Page S.L., White J.M., McCabe H.M., Zhang Y.-H., Therrell B.L., McCabe E.R.B. Unbiased analysis of the frequency of β-thalassemia point mutations in a population of African-American newborns. Arch. Path. Lab. Med. 117:1993;1110-1114.
45. Thein S.L., Winichagoon P., Hesketh C., Best S., Fucharoen S., Wasi P., Weatherall D.J. The molecular basis of β-thalassemia in Thailand: application to prenatal diagnosis. Am. J. Hum. Genet. 47:1990;369-375.
46. Huang S.-Z., Zhou X.-D., Zhu H., Ren Z.-R., Zeng Y.-T. Detection of β-thalassemia mutations in the Chinese using amplified DNA from dried blood specimens. Hum. Genet. 84:1990;129-131.
47. Saiki R.K., Walsh P.S., Levenson C.H., Erlich H.A. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc. Natl. Acad. Sci. USA. 86:1989;6230-6234.
48. Xu X., Liao C., Liu Z., Huang Y., Zhang J., Li J., Peng Z., Qiu L., Xu Q. Antenatal screening and fetal diagnosis of β-thalassemia in a Chinese population: prevalence of the β-thalassemia trait in the Guangzhou area of China. Hum. Genet. 98:1996;199-202.
49. Maggio A., Giambona A., Cai S.P., Wall J., Kan Y.W., Chehab F.F. Rapid and simultaneous typing of hemoglobin S, hemoglobin C and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. Blood. 81:1993;239-242.
50. Sutcharitchan P., Saiki R., Huisman T.H., Kutlar A., McKie V., Erlich H., Embury S.H. Reverse dot-blot detection of the African-American beta-thalassemia mutations. Blood. 86:1995;1580-1585.
51. Chan V., Yam I., Chan F.E., Chan T.K. A reverse dot blot method for rapid detection of non-deletional α-thalassemia. Br. J. Hematol. 104:1999;513-515.
52. Newton C.R., Graham A., Heptinstall L.E., Powell S.J., Summers C., Kalsheker, Smith J.C., Markham A.F. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17:1989;2503-2516.
53. Old J.M., Varawalla N.Y., Weatherall D.J. Rapid detection and prenatal diagnosis of β-thalassemia: studies in Indian and Cypriot population in the UK. Lancet. 336:1990;834-837.
54. Varawalla N.Y., Old J.M., Sarkar R., Venkatesan R., Weatherall D.J. The spectrum of β-thalassemia mutations on the Indian subcontinent: the basis of prenatal diagnosis. Br. J. Hematol. 78:1991;242-247.
55. Tan J.A., Tay J.S., Lin L.I., Kham S.K., Chia J.N., Chin T.M., Aziz N.B., Wong H.B. The amplification refractory mutation system (ARMS); a rapid and direct prenatal diagnostic technique for beta-thalassemia in Singapore. Prenat. Diagn. 14:1994;1077-1082.
56. Fortina P., Dotti G., Conant R., Monokian G., Parella T., Hitchcock W., Rappaport E., Schwartz E., Surrey S. Detection of most common mutations causing β-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). PCR Methods Appl. 2:1992;163-166.
57. Ahmed S., Saleem M., Sultana N., Raashid Y., Waqar A., Anwar M., Modell B., Karamat K.A., Petrou M. Prenatal diagnosis of beta-thalassemia in Pakistan: experience in a Muslim country. Prenat. Diagn. 20:2000;378-383.
58. Chang J.G., Liu H.J., Huang H.M., Yang T.Y., Chang C.P. Multiplex mutagenically separated PCR: diagnosis of β-Thalassemia and hemoglobin variants. Biotechniques. 22:1997;520-527.
59. Tan K.L., Tan J.A., Wong Y.C., Wee Y.C., Thong M.K., Yap S.F. Combine- ARMS: A rapid and cost effective protocol for molecular characterization of β-Thalassemia in Malaysia. Genet. Test. 5:2001;17-22.
60. Wayne J.S., Eng B., Hunt J.A., Chui D.H. Filipino beta-thalassemia due to a large deletion: identification of the deletion endpoints and polymerase chain reaction (PCR)-based diagnosis. Hum. Genet. 94:1994;530-532.
61. Bowden D.K., Vickers M.A., Higgs D.R. A PCR-based strategy to detect the common severe determinants of alpha thalassaemia. Br. J. Haematol. 81:1992;104-108.
62. Craig J.E., Barnetson R.A., Prior J., Raven J.L., Thein S.L. Rapid detection of deletions causing. δβ thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification Blood. 83:1994;1673-1682.
63. Bhardwaj U., Zhang Y.-H., Blackburn W., McCabe L.L., McCabe E.R.B. Rapid confirmation of Southeast Asian and Filipino. α -thalassemia genotypes from newborn screening specimens Am. J. Hematol. 71:2002;56-58.
64. Bhardwaj U., Zhang Y.-H., Sylvester-Jackson D., Buchanan G.R., Therrell B.L., McCabe L.L., McCabe E.R.B. DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up. J. Pediatr. 142:2003;346-348.
65. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86:1989;2766-2770.
66. Cotton R.G.H. Mutation Detection. 1997;Oxford University Press, New York.
67. Romey M.C., Aguilar-Martinez P., Demaille J., Claustress M. Rapid detection of single nucleotide deletions: application to the beta 6 (-A) mutation of the beta-globin gene and to cystic fibrosis. Hum. Genet. 92:1993;627-628.
68. Nataraj A.J., Olivos-Glander I., Kusukawa N., Highsmith W.E. Jr. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis. 20:1999;1177-1185.
69. Fodde R., Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum. Mutat. 3:1994;83-94.
70. Sheffield U.C., Cox D.R., Lerman L.S., Myers R.M. Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragment by the polymerase chain reaction results in improved detection of single base change. Proc. Natl. Acad. Sci. USA. 86:1989;232-236.
71. Vijg J., van Orsouw N.J. Two-dimensional gene scanning: exploring human genetic variability. Electrophoresis. 20:1999;1239-1249.
72. Losekoot M., Fodde R., Harteveld C.L., Van Heeren H., Giorano P.C., Bernini L.F. Denaturing gradient gel electrophoresis and direct sequencing of the PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta-thalassemia. Br. J. Hematol. 76:1990;269-274.
73. Gottardi E., Losekoot M., Fodde R., Saglio G., Camaschella C., Bernini L.F. Rapid identification by denaturing gradient gel electrophoresis of mutation in. γ -globin gene promoters in non-deletion type of HPFH Br. J. Hematol. 80:1992;533-538.
74. Audrezet M.P., Costes B., Ghanem N., Fanen P., Verlingue C., Morin J.F., Mercier B., Goossens M., Ferec C. Screening for cystic fibrosis in dried blood spots of newborns. Mol. Cell. Probes. 7:1993;497-502.
75. Maxam A.M., Gilbert W. A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA. 74:1977;560-564.
76. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
77. ′ terminus: synthesis of fluorescent DNA primers for use in DNA sequence analysis Nucleic Acids Res. 13:1985;2399-2412.
78. Smith L.M., Sanders J.Z., Kaiser R.J., Hughes P., Dodd C., Connell C.R., Einer C., Kent S.B., Hood L.E. Fluorescence detection in automated DNA sequence analysis. Nature. 321:1986;674-679.
79. Hood L.E., Hankapiller M.W., Smith L.M. Automated DNA sequencing and analysis of human genome. Genomics. 1:1987;201-212.
80. Hunkapiller T., Kaiser R.J., Koop B.K., Hood L. Large scale and automated sequence determination. Science. 254:1991;59-67.
81. Albarghouthi M.N., Barron A.E. Polymeric matrices for DNA sequenced by capillary electrophoresis. Electrophoresis. 21:2000;4096-4111.
82. Zhou H., Miller A.W., Sosic Z., Buchholz B., Barron A.E., Kotler L., Karger B.L. DNA sequencing up to 1300 bases in 2. h by capillary electrophoresis with mixed replaceable linear polyacrylamide solutions Anal. Chem. 72:2000;1045-1052.
83. Ward C.P., Fensom A.H., Green P.H. Biallelic discrimination assays for the three common Ashkenazi Jewish mutation and a common non-Jewish mutation, in Tay-sachs disease using TaqMan probes. Genet. Test. 4:2000;351-358.
84. Ballerini S., Bellincampi L., Bernardini S., Cascianis S., Motti C., Cortese C., Federici G. Apolipoprotein E genotyping: a comparitive study between restriction endonuclease mapping and allelic discrimination with the Lightcycler. Clin. Chem. Acta. 317:2002;71-76.
85. Moreno I., Bolufer P., Perez M.L., Barragan E., Sanz M.A. Rapid detection of major Mediterranean β-thalassemia mutation by real-time polymerase chain reaction using fluorophore-labelled hybridization probes. Br. J. Hematol. 119:2002;554-557.
86. Herrmann M.G., Dobrowolski S.F., Wittwer C.T. Rapid β-globin genotyping by multiplexing probe melting temperature and color. Clin. Chem. 46:2000;424-428.
87. Vrettou C., Traeger-Synodinos J., Tzetis M., Malamis G., Kanavakis E. Rapid screening of multiple β-globin gene mutations by real-time PCR on the Light cycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin. Chem. 49:2003;769-776.
88. Ramsay G. DNA chips: state-of-the-art. Nat. Biotechnol. 16:1998;40-44.
89. Southern E.M. DNA chips: analysis sequence by hybridization on a large scale. Trends Genet. 12:1996;110-115.
90. Southern E.M., Maskos U., Elder J.K. Analysis and comparing nucleic acid sequencing by hybridization to arrays of oligonucleotides: evaluation using experimental models. Genomics. 13:1992;1008-1017.
91. Fodor S.P.A., Read J.L., Pirrung M.C., Stryer L., Lu A.T., Solas D. Light directed spatially addressable parallel chemical synthesis. Science. 251:1991;767-773.
92. Beattie K.L., Beattie W.G., Meng L., Turner S.L., Coral-Vazquez R., Smith D.D., McIntyre P.M., Dao D.D. Advances in genosensor research. Clin. Chem. 41:1995;700-706.
93. Hacia J.G., Collins F.S. Mutational analysis using oligonucleotide microarrays. J. Med. Genet. 36:1999;730-736.
94. Cronin M.T., Fucini R.V., Kim S.M., Masino R.S., Waspi R.M., Miyada C.G. Cystic fibrosis mutation detection by hybridization to light generated DNA probe array. Hum. Mutat. 7:1996;244-255.
95. Bowtell D.D. Options available-from start to finish-for obtaining expression data by micro array. Nat. Genet. Suppl. 21:1999;25-32.
96. Yershov G., Barsky V., Belgoveki Y.A., Kirillov E., Kreindlin E., Ivanov I., Parinov S., Guschin D., Drobishev A., Dubiley S., Mirzabekov A. DNA analysis and diagnostics on oligonucleotide microchips. Proc. Natl. Acad. Sci. USA. 93:1996;4913-4918.
97. Gemignani F., Chiara P., Landi S., Canzian F., Kurg A., Tonisson N., Galanello R., Cao A., Metspaulu A., Romeo G. Reliable detection of β-thalassemia and G6PD mutations by a DNA microarray. Clin. Chem. 48:2002;2051-2054.
98. Shumaker J.M., Metspalu A., Caskey C.T. Mutation detection by solid phase primer extension. Hum. Mutat. 7:1996;346-354.
99. Pastinen T., Raitio M., Lindroos K., Tainola P., Peltonen L., Syvanen A.C. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res. 10:2000;1031-1042.